RF
NVO

Robinswood Financial’s Novo Nordisk NVO Stock Holding History

Robinswood Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479 Hold
10
– – ﹤0.01% 408
2026
Q1 		$367 Hold
10
– – ﹤0.01% 405
2025
Q4 		$508 Sell
10
-31
-76% -$1.58K ﹤0.01% 377
2025
Q3 		$2.27K Hold
41
– – ﹤0.01% 333
2025
Q2 		$2.83K Hold
41
– – ﹤0.01% 333
2025
Q1 		$2.85K Sell
41
-15
-27% -$1.24K ﹤0.01% 324
2024
Q4 		$4.82K Hold
56
– – ﹤0.01% 249
2024
Q3 		$6.67K Buy
56
+31
+124% +$4.13K ﹤0.01% 240
2024
Q2 		$3.57K Buy
+25
New +$3.31K ﹤0.01% 279

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Robinswood Financial's NVO Position: Q2 2026 in Review

Robinswood Financial held its Novo Nordisk (NVO) position steady in Q2 2026 at 10 shares worth $479. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Robinswood Financial first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.67K in Q3 2024. 383 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Robinswood Financial held 10 shares of Novo Nordisk worth $479 as of Q2 2026.
  • Robinswood Financial left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Robinswood Financial's portfolio in Q2 2026, its #408 holding.
  • Robinswood Financial first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Robinswood Financial's Novo Nordisk position peaked at $6.67K in Q3 2024.
  • 383 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.